Volumetric or time-based capnography for excluding pulmonary embolism in outpatients?

J Thromb Haemost. 2010 Jan;8(1):60-7. doi: 10.1111/j.1538-7836.2009.03667.x. Epub 2009 Oct 24.

Abstract

Background: Volumetric capnography is technically more demanding but theoretically better than the time-based alveolar deadspace fraction (P(a)CO(2) - EtCO(2))/P(a)CO(2) as a bedside diagnostic tool for excluding pulmonary embolism (PE) in outpatients.

Objective: We compared both diagnostic accuracy in patients with a suspected PE and positive D-dimer enzyme-linked immunosorbent assay results.

Patients and methods: In this clinical multicenter trial with prospective inclusion and 3-month follow-up, alveolar deadspace fraction was compared by receiver operating characteristic (ROC) analysis with other parameters derived from volumetric capnography.

Results: Capnography was performed in 239 patients, and 205 tests (86%) were conclusive. The incidence of PE was 33%. The alveolar deadspace fraction accuracy expressed with ROC curve analysis was 0.73 +/- 0.04. The diagnostic performances of parameters from volumetric capnography were not significantly better. Sixteen per cent [95% confidence interval (CI) 12-21%] of patients presented a (P(a)CO(2) - EtCO(2))/P(a)CO(2) ratio under the cut-off value of 0.15, with a low clinical probability. This combination excluded PE, with a sensitivity of 96% (95% CI 89-99%) and a negative likelihood ratio of 0.17 (95% CI 0.09-0.33%).

Conclusion: Volumetric capnography failed to show superiority to alveolar deadspace fraction measurements [(P(a)CO(2) - EtCO(2))/P(a)CO(2)] for exclusion of PE in outpatients with positive D-dimer test results. Future studies should clarify the safety of excluding PE in patients combining low clinical probability with positive D-dimer results and (P(a)CO(2) - EtCO(2))/P(a)CO(2) ratios below the cut-off value of 0.15.

Publication types

  • Clinical Trial
  • Comparative Study
  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Capnography*
  • Carbon Dioxide / metabolism*
  • Enzyme-Linked Immunosorbent Assay
  • Europe
  • Fibrin Fibrinogen Degradation Products / metabolism
  • Humans
  • Likelihood Functions
  • Middle Aged
  • Outpatients*
  • Point-of-Care Systems*
  • Predictive Value of Tests
  • Prospective Studies
  • Pulmonary Embolism / blood
  • Pulmonary Embolism / diagnosis*
  • Pulmonary Embolism / metabolism
  • ROC Curve
  • Respiratory Dead Space*
  • Sensitivity and Specificity
  • Time Factors

Substances

  • Fibrin Fibrinogen Degradation Products
  • fibrin fragment D
  • Carbon Dioxide